FGF23 was originally identified for its role in phosphate metabolism when mutated FGF23 was found in patients with autosomal dominant hypophosphatemic rickets (ADHR) [51], and FGF23 was identified as the causal agent in tumour-induced osteomalacia (TIO). Here, FGF23 is linked to autosomal dominant hypophosphatemic rickets.